Pexep
$ 42,00 – $ 162,00Price range: $ 42,00 through $ 162,00
Phexin
$ 70,00 – $ 374,00Price range: $ 70,00 through $ 374,00
Phenergan
$ 42,00 – $ 136,00Price range: $ 42,00 through $ 136,00
Phenergan is a versatile medication primarily used as an antihistamine to relieve symptoms of seasonal allergies, including runny nose and itchy eyes. It is highly effective in managing nausea and vomiting associated with various conditions, such as post-operative recovery or motion sickness. The medication helps prevent and treat the discomfort of dizziness while traveling by sea, air, or land. Beyond its allergy-fighting properties, Phenergan is frequently utilized to promote relaxation and light sedation before or after surgical procedures. This dependable treatment provides multi-symptom relief by addressing respiratory, digestive, and nervous system responses.
Active substance: Promethazine
SKU:
Phenergan
Categories: AntiAllergics, Anxiety, Pain Relief, Sleep Aid
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Phenergan belongs to a class of medications known as phenothiazines. It functions primarily as a first-generation H1-receptor antagonist with additional antiemetic, sedative, and anticholinergic properties. As a prescription-only medication regulated under US federal law, it is indicated for managing allergic reactions, motion sickness, postoperative nausea, and as an adjunctive sedative.
Clinical management with this drug requires explicit adherence to FDA-approved dosing parameters and awareness of central nervous system effects. The active pharmaceutical ingredient, promethazine hydrochloride, alters the actions of chemical substances in the brain and competes with histamine for H1-receptor sites.
| Property | Details |
|---|---|
| Drug name | Phenergan |
| Active ingredient | Promethazine hydrochloride |
| Therapeutic class | First-generation phenothiazine antihistamine / Antiemetic |
| Dosage form | Oral tablets, syrup, rectal suppositories, injection |
| Route of administration | Oral, rectal, intramuscular, intravenous |
| Primary purpose | Treatment of allergic conditions, motion sickness, nausea/vomiting, and pre/postoperative sedation |
| Prescription status | Prescription (Rx) |
Clinical Profile and Usage Information
How the drug works
The mechanism of action of Phenergan involves competitive blockade of peripheral H1 histamine receptors. By preventing histamine from binding to these sites, the drug suppresses histamine-mediated responses such as vasodilation, increased capillary permeability, and bronchoconstriction. Furthermore, promethazine acts on the chemoreceptor trigger zone (CTZ) in the medulla oblongata to inhibit signals that provoke nausea and vomiting. Its therapeutic profile also includes significant central anticholinergic activity, which contributes to its anti-motion sickness efficacy and sedative properties. The compound crosses the blood-brain barrier readily, leading to central nervous system depression.
Main uses
Phenergan is FDA-approved for several distinct clinical indications. It is prescribed for the symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis due to inhalant allergens and foods. It is also indicated for mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Beyond allergic conditions, the drug is used for the prevention and control of nausea and vomiting associated with anesthesia or surgery, as well as motion sickness prophylaxis. Additionally, it serves as an adjunctive sedative in preoperative, postoperative, and obstetric care. Unlabeled or off-label use for acute anxiety management is not established as a primary indication by the FDA and requires independent medical evaluation.
Dosing schedule
The dosage of Phenergan is individualized based on the clinical indication, patient age, body weight, and therapeutic response. For allergic conditions, the average adult dose is 25 mg administered at bedtime, or 12.5 mg taken before meals and at bedtime if necessary. For motion sickness prevention, the standard dose is 25 mg taken twice daily, with the initial dose taken 30 to 60 minutes prior to travel. For nausea and vomiting, the typical adult dosage ranges from 12.5 mg to 25 mg every 4 to 6 hours as needed. Administration forms include oral tablets, oral solution, and rectal suppositories, dispensed strictly in accordance with applicable federal and state regulations.
How it’s absorbed and eliminated
Promethazine hydrochloride is well absorbed from the gastrointestinal tract following oral or rectal administration. Clinical onset of action typically occurs within 20 minutes after oral intake, reaching peak concentration in plasma within 2 to 3 hours. The duration of pharmacological effect usually ranges from 4 to 6 hours, although sedative effects may persist for up to 12 hours in certain individuals. The drug undergoes extensive first-pass hepatic metabolism, primarily converting to promethazine sulfoxide and N-demethylpromethazine. Promethazine exhibits high plasma protein binding (approximately 93%). Elimination occurs slowly, with metabolites excreted primarily in the urine and unabsorbed drug excreted in the feces. The elimination half-life ranges approximately from 9 to 16 hours.
Important precautions
Phenergan carries a mandatory Boxed Warning regarding pediatric safety. The drug is strictly contraindicated in pediatric patients under 2 years of age due to the risk of severe, potentially fatal respiratory depression. Caution is required when administering the drug to pediatric patients 2 years of age and older, using the lowest effective dose. Severe tissue injury, including gangrene requiring amputation, has been reported following intravenous administration; intramuscular injection is the preferred parenteral route. Elderly patients are at increased risk for confusion, dizziness, hypotension, and anticholinergic side effects. Caution is recommended in individuals with lower respiratory tract conditions, bone marrow depression, narrow-angle glaucoma, or prostatic hypertrophy.
Compatibility with other medicines
Concomitant use of Phenergan with other central nervous system (CNS) depressants enhances sedation and respiratory depression. Dosage reductions are required when prescribed alongside sedatives, hypnotics, narcotics, general anesthetics, tranquilizers, or tricyclic antidepressants. The anticholinergic effects of promethazine are intensified when combined with atropine, scopolamine, or other belladonna alkaloids. Concurrent administration with monoamine oxidase (MAO) inhibitors can prolong and intensify anticholinergic and CNS depressive actions. Additionally, promethazine may interfere with diagnostic tests, such as pregnancy tests based on immunological reactions, producing false-positive or false-negative results.
Adverse reactions
The most frequently observed adverse reaction to Phenergan is somnolence or severe daytime sedation. Other central nervous system side effects include dizziness, confusion, disorientation, fatigue, incoordination, and blurred vision. Anticholinergic reactions commonly consist of dry mouth, urinary retention, constipation, and thickened bronchial secretions. Less common but severe cardiovascular reactions include hypotension, bradycardia, or tachycardia. Extrapyramidal symptoms, such as restlessness, tremor, or involuntary muscle movements, may develop. Paradoxical excitation, agitation, and insomnia can occur, particularly in pediatric or geriatric populations.
What to avoid while taking it
Ethanol markedly exacerbates the central nervous system depressant effects of promethazine hydrochloride. Patients must avoid alcohol and alcohol-containing formulations during therapy. Concomitant intake of rich or heavy meals does not significantly affect systemic absorption, but taking oral formulations with food or milk may diminish localized gastrointestinal upset. Due to the marked decrease in mental alertness and physical coordination, activities requiring extreme mental acuity–such as operating heavy machinery, driving motor vehicles, or performing hazardous high-altitude work–must be strictly avoided while taking Phenergan.
Red flags
Certain severe reactions require immediate cessation of the drug and rapid clinical intervention. Emergence of respiratory depression, severe extrapyramidal symptoms, or signs of Neuroleptic Malignant Syndrome (NMS)–characterized by hyperpyrexia, muscle rigidity, altered mental state, and autonomic instability–demands emergency medical care. Parenteral administration sites showing pain, swelling, burning, or skin discoloration must be evaluated immediately to prevent ischemic tissue necrosis.
| Emergency Sign | Clinical Significance |
|---|---|
| Swelling of the face, lips, tongue, or throat | Possible severe hypersensitivity / anaphylaxis |
| Shallow, slow, or difficult breathing | Severe respiratory depression risk |
| High fever with muscle stiffness and confusion | Potential Neuroleptic Malignant Syndrome (NMS) |
| Involuntary muscle movements or tremors | Extrapyramidal side effect presentation |
| Severe injection site pain, pallor, or burning | Possible extravasation and tissue necrosis |
If you skip a dose
If a dose of Phenergan is missed, it should be taken as soon as remembered, provided the next scheduled dose is not imminent. If the time is close to the subsequent scheduled dose, the missed dose should be omitted entirely, resuming the standard dosing regimen. Patients must never double the dose to compensate for a skipped administration, as excessive promethazine accumulation increases the risk of severe respiratory depression and profound CNS sedation.
Storage and expiration
Phenergan preparations must be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). Formulations must be protected from light and moisture exposure. Rectal suppositories should be kept in their original foil packaging and refrigerated if environmental temperatures risk softening the product. Any drug past its stated expiration date must be disposed of safely according to federal, state, and local pharmaceutical waste regulations.
Patient Guidance and Common Questions
Can Phenergan cause severe daytime drowsiness?
Drowsiness is the primary pharmacological effect of promethazine due to its ability to cross the blood-brain barrier and block central H1 receptors. Patients frequently experience diminished alertness and psychomotor impairment lasting 4 to 12 hours. Motor vehicle operation or hazardous equipment use should be suspended until individual tolerance is determined.
Why is Phenergan contraindicated in children under two years old?
The FDA issued a Boxed Warning restricting the use of promethazine in pediatric patients under 2 years of age due to the risk of fatal respiratory depression. Post-marketing surveillance data demonstrated cases of severe respiratory arrest in infants receiving standard weight-based doses, making its administration in this age group unsafe under any circumstance.
What should be done if a dose is missed?
A missed dose should be taken only if there is a significant interval before the next scheduled administration. If the next dose is due shortly, the missed dose should be bypassed to prevent drug accumulation. Doubling doses increases toxicity risk and does not enhance therapeutic efficacy.
How does alcohol affect the therapeutic outcome of Phenergan?
Alcohol exerts an additive depressant effect on the central nervous system when combined with promethazine. This interaction can lead to severe sedation, profound psychomotor impairment, respiratory depression, and extreme hypotension. Concurrent ingestion of alcoholic beverages is strictly advised against during treatment.
This text is for informational purposes only and does not constitute individual medical advice. In accordance with FDA requirements.
Additional information
| Dosage |
25mg |
|---|---|
| Package |
90 pills ,120 pills ,180 pills ,270 pills ,360 pills |
| Ενεργός Ουσία |
Related products
Aristocort
$ 67,00 – $ 602,00Price range: $ 67,00 through $ 602,00
Active substance: Triamcinolone
More Details
This product has multiple variants. The options may be chosen on the product page
Decadron
$ 12,00 – $ 182,00Price range: $ 12,00 through $ 182,00
Active substance: Dexamethasone
More Details
This product has multiple variants. The options may be chosen on the product page
Deltasone
$ 47,00 – $ 296,00Price range: $ 47,00 through $ 296,00
Active substance: Prednisone
More Details
This product has multiple variants. The options may be chosen on the product page
Flixotide Nasal Spray 100 doses
$ 54,00 – $ 220,00Price range: $ 54,00 through $ 220,00
Active substance: fluticasone
More Details
This product has multiple variants. The options may be chosen on the product page
FML Forte
$ 43,00 – $ 166,00Price range: $ 43,00 through $ 166,00
Active substance: Fluorometholone
More Details
This product has multiple variants. The options may be chosen on the product page
Haridra
$ 48,00
Active substance: Haridra
More Details
This product has multiple variants. The options may be chosen on the product page
Ketotifen
$ 67,00 – $ 309,00Price range: $ 67,00 through $ 309,00
Active substance: Ketotifen
More Details
This product has multiple variants. The options may be chosen on the product page
Montair
$ 19,00 – $ 45,00Price range: $ 19,00 through $ 45,00
Active substance: Montelukast
More Details
This product has multiple variants. The options may be chosen on the product page
